Ozego Cream contains Ozenoxacin 1% w/w, a non-fluorinated quinolone antibiotic indicated for the topical treatment of impetigo and other superficial bacterial skin infections caused by susceptible strains of Staphylococcus aureus and Streptococcus pyogenes. Ozenoxacin exhibits bactericidal activity by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair. The cream formulation allows for targeted delivery to the affected skin areas, minimizing systemic absorption and reducing the risk of systemic side effects. Ozego Cream is typically applied twice daily to the affected area for a duration of 5 days or as directed by a healthcare professional. It is contraindicated in patients with known hypersensitivity to ozenoxacin or any component of the formulation. Common adverse reactions are generally mild and may include local irritation, itching, or erythema at the application site. Caution is advised when using Ozego Cream on large areas or broken skin to avoid potential systemic exposure. The product should be stored at room temperature, protected from light and moisture. Ozego Cream offers an effective topical antimicrobial option for managing uncomplicated superficial bacterial skin infections, promoting rapid resolution and reducing the risk of bacterial resistance.